SEARCH
Current Location:
>
> This Story

starstarstarstarstar (1)
Log in or Register to rate this News Story
Forward Printable StoryPrint Send us your Comments

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

Mass. health care cost transparency law underperforming Pricing still murky after transparency law introduced

FDA approves Siemens' ultrasound with true volume 3-D TEE probe The system offers real-time blood flow and valve measurements in seconds

Robotic MR-guided needle performs brain surgery through cheek No need to drill through patient's skull

MEDICA's education conference: where innovations merge The four-day conference will discuss relationships between science and medical technology

Barco launches new diagnostic display system The system may provide radiologists with some needed relief

Konica Minolta gets FDA clearance for AeroDR XE Portable radiography panel is specially designed for use under ER and ICU conditions

ESR calls for safer and more appropriate use of imaging Campaign intends to limit number of radiological exams performed

Hafner heads to Varian The former senior director of Global Sales and Marketing for Philips/Dunlee makes a move

Ebola outbreak continues to spread exponentially The epidemic calls for a unified worldwide effort, and a level head

Agilent shuts down nuclear magnetic resonance business Did not meet growth goals

A human embryo that
was fertilized by IVF
(Courtesy of Dr. B. Behr and the
Clinical Embryology Laboratory
at the Stanford IVF Clinic)

A new method predicts the success of in vitro fertilization

by Olga Deshchenko , DOTmed News Reporter
A novel method can help predict with 70 percent accuracy whether a woman undergoing in vitro fertilization (IVF) treatment for the second time will become pregnant, a new study found.

Researchers at the Stanford University School of Medicine identified four factors that determine a woman's chances of getting pregnant from an IVF cycle. Dr. Mylene Yao, an assistant professor of obstetrics and gynecology at the university, led the research.

Story Continues Below Advertisement

OiHealthcare - ISO 9001 & 13485 Certified - Call 888-673-5151

Oxford Instruments Healthcare, is a leading ISO 9001 & 13485-certified organization, that specializes in providing quality after-market GE CT and MRI systems, service and parts - at prices you can afford.



"We developed this prediction tool to provide high quality, personalized information that women and their physicians could use to support their decision-making in IVF," Yao wrote in an e-mail to DOTmed News. "This prediction tool also paves the way towards research that will help us better understand mechanisms of infertility."

During an IVF treatment, a woman is given drugs to stimulate ovulation. Her eggs are then removed from the ovaries and combined with sperm in a culture dish. Doctors then use a variety of criteria to determine which embryos produced in the IVF cycle are most likely to result in a live birth. However, the factors doctors take into consideration are not personalized.

According to the Society for Assisted Reproductive Technology, IVF cycles result in pregnancy for women using their own eggs about 18 to 45 percent of the time, depending on age and other variables.

Yao and her team of researchers analyzed clinical data from 665 IVF cycles performed at Stanford in 2005. They examined 30 different variables and looked at the connection of each variable with the IVF outcome. The researchers found that four factors were most important in determining a woman's chance of becoming pregnant through an IVF cycle: total number of embryos, number of eight-cell embryos, percentage of embryos that stopped dividing and would die, and the woman's follicle-stimulating hormone level (a measurement that estimates ovarian function).

Yao said the new method has a lot of implications for women trying to decide to go through a second IVF treatment.

"First, the ability to use information from the first IVF treatment to predict outcomes in subsequent cycles may cause the first IVF treatment to be viewed as a prediction test, in addition to being a treatment," Yao said. "The availability of personalized information may encourage more women to take at least one IVF treatment."

Yao also said patients who may decide to drop out after the first failed treatment can make a more informed decision about continuing with further IVF treatments.

"Results pertaining to the relative influence of each factor with respect to outcome prediction will also form new paradigms for thinking about the causes for IVF, and how to develop treatments that will target specific mechanisms," said Yao.

Yao and her collaborator, Wing Wong, have founded a company together called Univfy Inc. to develop and market the new method, she said.

"We hope to make this technology accessible to patients and physicians nationwide, subject to FDA clearance," Yao said.





Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2014 DOTmed.com, Inc.
ALL RIGHTS RESERVED